AJP - GI AJP: Gastrointestinal and Liver Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Gastrointest Liver Physiol 293: G979-G986, 2007. First published August 23, 2007; doi:10.1152/ajpgi.00310.2007
0193-1857/07 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
293/5/G979    most recent
00310.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by de Godoy, M. A. F.
Right arrow Articles by Rattan, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by de Godoy, M. A. F.
Right arrow Articles by Rattan, S.

HORMONES AND SIGNALING

Role of phospholipase A2 (group I secreted) in the genesis of basal tone in the internal anal sphincter smooth muscle

Márcio A. F. de Godoy and Satish Rattan

Department of Medicine, Division of Gastroenterology and Hepatology, Jefferson Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania

Submitted 10 July 2007 ; accepted in final form 22 August 2007

The role of phospholipase A2 (PLA2) in the genesis of basal tone in the internal anal sphincter (IAS) is not known. We determined the effects of PLA2 and inhibitors on the basal tone and intraluminal pressures (IASP) in the rat IAS vs. rectal smooth muscles (RSM). In addition, we determined the correlations between the IAS tone, PLA2 levels, and the actual enzymatic activity. Inhibition of PLA2 by 4-bromophenacyl bromide (universal inhibitor of PLA2) and MJ33 [selective inhibitor of secreted isoform of PLA2 (sPLA2)] caused concentration-dependent decrease in the IAS tone and in the IASP. Maximal decreases in the IAS tone and IASP by 4-bromophenacyl bromide and MJ33 were 58.8 ± 6.9 and 51.5 ± 6.3%, and 66.7 ± 5.1 and 79.8 ± 8.2%, respectively. The sPLA2 inhibitors were ~100 times more potent in decreasing the IASP than the mean blood pressure. Conversely, the selective inhibitors of the cytosolic and calcium-independent PLA2 arachidonyl trifluoromethyl ketone and bromoenol lactone, respectively, produced no significant effect. The IAS had characteristically higher levels of sPLA2 activity (26.5 ± 4.9 µmol·min–1·ml–1) vs. the RSM (3.2 ± 0.4 µmol·min–1·ml–1), and higher levels of sPLA2 as shown by Western blot and RT-PCR. Interestingly, administration of sPLA2 transformed RSM into the tonic smooth muscle like that of the IAS: it developed basal tone and relaxed in response to the electrical field stimulation. From the present data, we conclude that sPLA2 plays a critical role in the genesis of tone in the IAS. PLA2 inhibitors may provide potential therapeutic target for treating anorectal motility disorders.

smooth muscle tone; rectoanal incontinence



Address for reprint requests and other correspondence: S. Rattan, Dept. of Medicine, Division of Gastroenterology and Hepatology, Thomas Jefferson Univ., 1025 Walnut St., Rm. #901 College, Philadelphia, PA 19107 (e-mail: Satish.Rattan{at}Jefferson.edu)







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.